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Abstract— Tumor protein P53 is believed to be involved in over half of human cancers cases, the prediction of malignancies plays essential 
roles not only in advance detection for cancer, but also in discovering effective prevention and treatment of cancer, till now there isn't ap-
proach be able in prediction the mutated in tumor protein P53 which is caused high ratio of human cancers like breast, Blood, skin, liver, 
lung, bladder etc. This research proposed a new approach for prediction   pre-cancer via detection malignant mutations in tumor protein P53 
using bioinformatics tools like FASTA, BLAST, CLUSTALW and TP53 databases worldwide. Implement and apply this new approach of 
prediction  pre-cancer through mutations at tumor protein P53 shows an effective result when used more specific parameters/features to ex-
tract the prediction result that means when the user increase the number of filters of the results which obtained from the database gives 
more specific diagnosis and classify, addition that the detecting pre-cancer via prediction mutated tumor protein P53 will reduces a person's 
cancers in the future by avoiding exposure to toxins, radiation or monitoring themselves at older ages by change their food, environment, 
even the pace of living. Also that new approach of prediction pre-cancer will help if there is any treatment can give for that person to therapy 
the mutated tumor protein P53. 
 
Index Terms— Normal Homology TP53 gene, Tumor Protein P53, Oncogene Labs, GC% and AT% content, FASTA, BLAST, ClustalW  
——————————      —————————— 
1 INTRODUCTION     
P53  gene provides instructions for making a protein 
called tumor P53 protein. This protein as a tumor sup-
pressor, which means it regulates cell division by keeping 
cells grow and divide very rapidly or in an uncontrolled man-
ner. P53 tumor protein is located in the nucleus of cells 
throughout the body, where it connects directly to DNA.  
 
TP53 gene (Cytogenetic) Location: 17p13.1, Molecular Lo-
cation on chromosome 17: base pairs 7,571,719 to 7,590,867. 
Fig. 1 shows the TP53 gene is located on the short (p) arm of 
chromosome 17 at position 13.1. More precisely, the TP53 gene 
is located from base pair 7,571,719 to base pair 7,590,867 on 
chromosome 17 [1]. 
 
 
 
 
 
 
 
 
 
 
 
 
1979 the P53 gene, later found to be the most frequently 
mutated gene in human cancer, is discovered. Since the 
discovery of a gene human due to tumor cancer in 1981, called 
oncogene, primary cause of cancer is the occurrence of 
mutations in specific genes (the important one TP53 gene 
which caused of cancers), as a result of exposure to toxins or 
radiation or by processes corrective wrong of DNA or the 
result of errors that occur when transcription of DNA before 
cell division, addtional the advance in old may play role at 
exchange genatic cells means the DNA and the RNA reached 
to turom protien P53 and in the final causes the cancers [2]. 
There are factors due to injury with cancer and distortion 
material genetic such as distortion physical factors such as 
gamma-ray ionizing liberated from the nuclei of atoms of 
heavy elements or high-energy particles such as alpha or beta 
particles and high temperatures. In addition to chemical 
factors such as the concentrations of chemical compounds that 
interfere with the body either through food or drink, breathe, 
or even some mechanical factors such as an impressive blow 
against the body causes of the machine lead to inflammation 
and the decline of blood or other and these are the 
environmental impacts.  And cancer is a tumor and cirrhosis 
caused by cancer cells. 
 
Well known that with the aging increases the risk of cancer 
and the reason is mainly the result of accumulated hurt the 
DNA with the passage of time. A new study suggests another 
reason for the increased incidence of cancer in the elderly, and 
is diminishing the effect of the gene responsible for the fight 
against cancer TP53. Where named P53 gene is one of the most 
important genes which operates inhibitor to cancer, which 
makes the cell response to repair or suicide cell, otherwise will 
cause cancers, and it found more than 50% of cancer patients 
have mutations in the gene P53 [3].  
 
The changes in the TP53 gene related with cancers (skin, liv-
er, lung, bladder, breast, head and neck, esophagus, stomach 
and colorectal cancers, and hematological malignancies), as 
follow [1, 4]:  
A. Breast cancer - increased risk from variations of the TP53 
gene: Changes in the TP53 gene greatly increase the risk of 
T 
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Fig. 1 TP53 gene is located on the short (p) arm of chromosome 
17 at position 13.1 
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developing breast cancer as part of a rare inherited cancer 
syndrome called Li-Fraumeni syndrome. These inherited 
mutations are thought to account for less than 1 percent of 
all breast cancer cases. Somatic mutations in the TP53 gene 
are much more common, occurring in approximately 20 
percent to 40 percent of all breast cancer cases. Many of 
these mutations change a single protein building block 
(amino acid) in tumor protein p53. These mutations lead to 
the production of a nonfunctional version of this protein.  
B. Bladder cancer - associated with the TP53 gene: Some gene 
mutations are acquired during a person's lifetime and are 
present only in certain cells. These changes, which are 
called somatic mutations, are not inherited. Somatic TP53 
mutations in bladder cells have been found in some cases 
of bladder cancer. Most of these mutations change a single 
protein building block (amino acid) in tumor protein p53. 
C. Li-Fraumeni syndrome - associated with the TP53 gene: 
Although somatic mutations in the TP53 gene are found in 
many types of cancer, Li-Fraumeni syndrome appears to be 
the only inherited cancer syndrome associated with muta-
tions in this gene. More than 60 different mutations in the 
TP53 gene have been identified in individuals with Li-
Fraumeni syndrome. These mutations are typically inherit-
ed from a parent and are present in all of the body's cells. 
Many of the mutations associated with Li-Fraumeni syn-
drome change a single protein building block (amino acid) 
in the part of tumor protein p53 that binds to DNA.  
D. Other cancers - associated with the TP53 gene: Somatic 
mutations in the TP53 gene are the most common genetic 
changes found in human cancer, occurring in about half of 
all cancers. For example, TP53 mutations have been identi-
fied in several types of brain tumor, colorectal cancer, a 
type of bone cancer called osteosarcoma, a cancer of mus-
cle tissue called rhabdomyocarcinoma, and a cancer called 
adrenocortical carcinoma that affects the outer layer of the 
adrenal glands (small hormone-producing glands on top of 
each kidney). 
 
Most TP53 mutations change single protein building blocks 
(amino acids) in tumor protein p53, which leads to the produc-
tion of an altered version of the protein that cannot bind effec-
tively to DNA. This defective protein can build up in the nu-
cleus of cells and prevent them from undergoing apoptosis in 
response to DNA damage. The damaged cells continue to 
grow and divide in an unregulated way, which can lead to 
cancerous tumors. 
 
The big problem happens when the change at TP53 will 
product type of P53 protein can't work normally, i.e. it can't 
regulates cell division by keeping cells grow and divide very 
rapidly or in an uncontrolled manner, moreover defective pro-
tein can build up in the nucleus of cells and prevent them 
from undergoing apoptosis in response to DNA damage. As 
results foreword their high risk of developing cancers in 
breasts, bladder, brain, osteosarcoma etc. Whenever the per-
son can diagnosis and predict the change at P53, that will 
make the person can take steps to reduce their risk of develop-
ing or lead to cancerous tumors, while for persons which 
holder to the mutated gene causes the cancer disease, in this 
case the person can monitor changes in breasts, bladder, brain, 
etc carefully to find cancer at an earlier, more treatable stage 
[4]. So needed an approach to diagnosis and predict to find the 
product P53 protien is normal or abnormal, means pre-cancer 
technique via detection mutations change at single protein 
building blocks (amino acids) in tumor protein P53. 
2 RELATED WORK 
Jonas Carlsson, Thierry Soussi, and Bengt Persson [2009], a 
method has been developed to predict the effects of mutations 
in the p53 cancer suppressor gene. The new method uses nov-
el parameters combined with previously established parame-
ters. The most important parameter is the stability measure of 
the mutated structure calculated using molecular modelling. 
For each mutant, a severity score is reported, which can be 
used for classification into deleterious and nondeleterious. 
Both structural features and sequence properties are taken into 
account. The method has a prediction accuracy of 77% on all 
mutants and 88% on breast cancer mutations affecting WAF1 
promoter binding. This study done investigated of correla-
tions between human p53 mutants found in cancer patients 
and the corresponding activity of promoter binding. The aim 
was to obtain a better understanding of molecular mecha-
nisms to explain why certain mutations cause more severe 
effects than others and to be able to predict the severity of 
new, hitherto uncharacterized mutants [3]. 
 
Ichikawa A., Hotta T., Takagi N., and others [2011], the al-
teration of p53 tumor suppressor gene was studied in 48 pa-
tients with 8-cell lymphoma. A sequential combined technique 
of polymerase chain reaction-mediated single strand confor-
mational polymorphism (PCR-SSCP) or reverse transcription 
(RT)-PCR-SSCP and direct sequencing were used as a simple 
and sensitive approach to analyze nucleotide changes. By the-
se methods, we identified 8 missense point mutations and 2 
codon deletions in 9 of the 48 patients. These mutations were 
located in or close to the evolutionally [5]. 
 
The drawbacks of these methods and techniques focus in di-
agnostic or prediction base on features of mutations in disease's 
genes not in genome sequence and for patients have cancer and 
not pre-cancer. The motivation overcome the drawbacks of the 
previous techniques to reach a new approach for prediction 
pre-cancer via detection mutated in tumor protein P53, by 
considering and introducing multi other features show the 
alternations, changes in the environment as well as TP53 gene, 
comparing sequences to gain information about the struc-
ture/function of a query sequence. Also proposing optimal 
and more accurate approach for classification and dealing 
with specific TP53 database and taking into consideration de-
pending on the idea of “two sequences may have big differences 
in DNA sequence but have similar protein” [6, 7]. So will not 
stop at TP53 gene sequence but will considered the mutations at 
tumor protein P53 protein of TP53) which is play important role 
as a tumor suppressor.  
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3 PROPOSED OF NEW APPROACH FOR PREDICTION 
PRE-CANCER VIA DETECTION MUTATED IN P53  
The survival rate is high with early diagnosis, 97% of women 
survive for 5 years or more years, Predicting malignancies 
plays essential roles not only in revealing human genome, but 
also in discovering effective prevention and treatment of can-
cers, curing from this malicious disease is mainly based upon 
early and accurate diagnosis computer aided diagnosis can be 
a good helper in this area [6]. 
 
The new approach of prediction pre-cancer via detecting 
mutated in tumor protein P53 will base on bioinformatics tools 
using normal TP53 gen and its protein [6], after satisfying that 
normal homo TP53 gene is represented to the environment by 
checkup GC% content [7]. The important feature needed with 
this proposed approach the TP53 database used to classify and 
diagnosis the malignant mutations at tumor protein P53 be-
cause this protein at level of certain codon will see there is 
multiple malignant mutations caused to multiple types of can-
cers can not predicting and detection them without TP53 da-
tabase, and the better select which related to its' environment. 
The proposed algorithm of new approach shown as follow: 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
4 EXPERIMENTAL RESULTS 
4.1 Bioinformatics Techniques 
The implement and apply of new approach for prediction pre-
cancer using BioEdit ver. 7.2.0 as shown in the following steps: 
1. Obtain the person's TP53 gene sequence from onco-
gene labs will use it in FASTA format to reach the 
normal homology of TP53 gene using BioEdit pack-
age. 
2. Reach to Normal homology TP53 gene using BioEdit 
by select World Wide Web BLAST at NCBI nu-
cleotide blast  Paste or upload from file the person's 
TP53 gene sequence which is formatted in FASTA as 
shown in Fig. 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                            
3. This step gives two options to get the normal TP53 
gene sequence as shown in Fig. 3. When click one of 
them will reach to normal homology TP53 gene as 
shown Fig. 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
       
 
 
Fig. 2 Shows how can obtain the Normal homology TP53 gene. 
 
Fig. 3 Shows options of reach to normal homology TP53 gene. 
 
Algorithm of new approach for prediction pre-cancer via 
detecting mutated in tumor protein P53  
Input: DNA sequence (normal and person’s gene sequence). 
Output: Diagnose and predict there are malignant mutations of person's 
               tumor protein P53 or not (No risk). 
BEGIN 
   Step 1: Get the TP53 person's gene sequences 
   Step 2: Put that TP53 person's gene sequences in FASTA format;  
   Step 3: Using BioEdit package to search about the normal homology 
                TP53 gene using BLAST NCBI 
   Step 4: Calculate the GC% and AT% of normal homology TP53 gene 
               using BioEdit package 
   Step 5: if GC% equal or greater than 38% then 
                     Depend it as normal PT53 gene for test person's TP53 gene 
                else 
                     Find another normal homology TP53 gene seguence form  
                       another database like EBI, Ensemble, etc and return to step 4 
   Step 6: CREATE fasta file contains the depended normal homology 
                TP53 gene and person's TP53 gene;  
   Step 7:  SET fasta file to clustalW for alignment; display alignment result 
   Step 8: if there is mutations  
                       Translate the normal TP53 gene and the person TP53 gene to 
                     proteins using BioEdit package. 
                     if there is mutations   // Classification there is mutations 
                             Sereach T53 database for matching (pre-cancer dedection) 
                           if there is matching  
                                Retrieve the biologic references of the cancer (types, 
                                names, positions, etc) 
                           else 
                                unknown cancer  
                     else 
                          No risk 
                else 
                     No rsik 
END 
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4. Open the BioEdit package with the normal gene of 
TP53 (Fasta file) which obtained in step (3) to calcu-
late the GC% content by select sequence option 
Nucleic Acid Nucleotide Composition, that will 
give the GC% whether equal or greater than 38%, Fig. 
5 shows it satisfy 54.85%, so will go to the next step,  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
otherwise will return to step 2 to find another data-
base to reach from it to the normal TP53 gene satisfy-
ing GC% >= 38%, and then continue with the same 
step 3, step 4 etc. 
5. Create fasta file contains the selected normal homolo-
gy TP53 gene and the person's TP53 gene.  
6. Using that fasta file which obtained in step (5) to 
clustalW to display alignment result, i.e. diagnosis 
there is malignant mutations by comparing the nor-
mal TP53 gene sequence with one (or more than one) 
person's TP53 gene sequences at the same time. That 
is done by BioEdit will select Accessory Applica-
tion ClustalW Multiple Alignment Run 
ClustalW, then obtained the result whether there is 
malignant mutation or not, and in this example will 
see mutation at person's TP53 gene comparing with 
normal TP53 gene as shown in Fig. 6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
7. That not enough so needed to transform to tumor 
protein P53 of normal homology TP53 gene and P53 
protein to person's TP53 gene then using the same 
tool ClustalW at BioEdit package to diagnosis there is 
malignant mutations as done in step (6) or not (No 
risk), Fig. 7 shows there is malignant mutations at 
codon 248 (CGG TGG), i.e will find the codon 248 
converted from R (at Normal P53) to W (at Person's 
P53 gene).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8. This step used to classify that malignant mutations 
which are discovered at step (7) to predict pre-cancer 
for persons by determine the cancer(s) may be related 
to these mutations which expected  there is multiple 
types related with each mutated codon in tumor pro-
Fig. 6. Shows mutation at person's TP53 gene comparing with normal TP53 
gene. 
.  
 
Fig. 7. Shows there is malignant mutations at codon 248 (CGG TGG).  
 
Fig. 5. Shows GC% content and AT% content 
.  
 
Fig. 4. The normal homology TP53 gene. 
.  
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tein P53, e.g. the mutation in codon 248 will need da-
tabase of TP53 (P53) gene and is better related with 
environment (locally database represent the persons, 
means if the person from Asia better to be this data-
base of TP53 from Asia, more specific in Middle east, 
or national database, etc.). For that resons to imple-
ment and applying the proposed approach will select 
the database (UMD_Cell_line_2010) of TP53 website 
as modern and comprehensive datatbase (URL: 
http://p53.free.fr/Database/p53_MUT_MAT.html) 
[8] , can use any other locally database related to en-
vironment because it become more representative in 
the case of pre-diagnosis and prediction of cancer. 
Fig. 8, explain how can get full related information 
like the insert, update, delet, etc of mutation which is 
discovered at person's P53 gene. Addition can obtain 
very specific oncogene laboratories information relat-
ed to mutated codon (248) by implement more than 
one filter for the certain fields like Codon, Mutated 
codon, Cancer, etc. Fig. 9 shows example using this 
TP53 database, how can obtain more specific results 
by doing the filters using more attributes to co-
don=248, Mutated codon= TGG, and Cancer= Colo-
rectal carcinoma respectively, and increasing the at-
tributes make reached to more specific results. 
 
 
 
 
 
 
 
 
 
 
 
  
9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The results of pre-cancer prediction which obtained from 
Applying the proposed approach shows multiple cancers may 
be caused by certain codon, Therefore, even among patients 
with cancers of the same body organ or tissue, the genetic pro-
file of each individual’s tumor can differ greatly [2], e.g. co-
don=248 gives various cancers as shown in Fig. 8, and certain 
cancer in different structures as shown in Fig. 9. Sometime 
may reach to nothing, but in the cases of there is malignant 
mutation but unknown cancer or the effect which is caused. In 
the case of diagnosis multiple cancers must be using multiple 
features include the mutated codon which caused the cancer 
to extract the specific results that will help to detect and diag-
nosis pre-cancer(s) (prediction) which may infect that person 
in future. 
 
4.2 Discussion the Results 
Table 1 show comparing the results of proposed approach for 
prediction pre-cancer via detecting mutated P53 with other 
techniques or methods.  
TABLE 1 
REVEALS COMPARISON OF PROPOSED APPROACH WITH 
OTHER TECHNIQUES OR METHODS 
Proposed Approach for 
Prediction Pre-cancer via 
Detacting Mutated P53  
A Ichikawa, 
T Hotta, N 
Takagi, and 
others [5] 
Jonas Carlsson, 
Thierry Soussi, 
and Bengt 
Persson [3] 
Proposed approach for 
Prediction pre-cancer 
approach di-
agnose and 
monitoring 
after infecting  
cancer 
approach diag-
nose and moni-
toring after  
infecting  can-
cer 
Diagnose and Detecting 
malignant mutations 
based on datasets se-
quences of Normal TP53 
gene and person's TP53 
gene with their tumor 
proteins P53. 
It works di-
rect with Per-
son's TP53 
gene and its 
tumor protein 
P53 only 
It works direct 
with Person's 
TP53 gene and 
its tumor pro-
tein P53 only 
Cost-effective for analysis 
where the cost about 
$3000 (cost of obtain P53 
sequence from oncogene 
labs[6] 
Does not have 
this  Cost-
effective 
Does not have 
this  Cost-
effective 
Considered the GC% and 
AT% content to select the 
Normal TP53 gene. 
There isn't There isn't 
Classifying and diagno-
ses of malignant muta-
tions at P53 needed TP53 
database or TP53 website 
because there is a large 
number of malignant mu-
tations and types of can-
cers associated with P53. 
There isn't  There isn't  
This proposed approach  
friendly to use by re-
searcher,  molecular bio-
logic, Biomedical, etc 
Limited  Limited 
 
Fig. 8. Shows explain how can get full related information like the insert, 
update, delet, etc. 
Fig. 9. Shows the more specific result by doing multiple filters on codon=248.  
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5 CONCLUSTIONS  
The proposed approach of prediction pre-cancer detecting via 
mutations disease at tumor protein P53 shown the following 
conclusions:  
 
A. The proposed approach offers friendly diagnosis and  
detecting malignant mutations and of pre-cancers as 
shown in Table 1, i.e. can use by researcher or any 
person who needed to test malignant mutations at 
TP53 gene and its' protein (P53) which caused more 
than 50% human cancers. 
B. This new approach is more effective when used query 
of TP53 database with multiple attributes/features to 
extract specific result as shown in subsection 4.1; step 
8, i.e. when the user increase the number of filters this 
approach will give more specific result, and  vice ver-
sa. 
C. The proposed approach shows the detecting pre-
cancer via predicting mutated P53 gene reducing of 
infect in cancers by avoiding exposure to toxins, radi-
ation or  when monitoring themselves at older ages 
and change their food, environment, even their living,  
addition if there is any treatment can give for that 
person to therapy the mutated tumor protein P53. 
D. The proposed approach of prediction pre-cancer must 
be based on collection datasets (normal TP53 gene 
and its tumor protein P53), as well as the TP53 data-
base if exist which used for diagnosis and classify the 
type of malignant mutations and the cancer may 
caused in tumor protein P53 related to environment 
that means the prediction is more expressive for the 
region and will be better as this as have seen from the 
above impact on the results and how it could affect 
the environment.  
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